"I have tried so many other sunscreens and always come back to this one." ...
The fate of Grail's stock will ultimately be decided in the cost-benefit calculations of medical insurers.
Grail is partnering with Samsung to move into Asia. The innovative cancer test maker just got major new sources of funding. Well, Grail makes a multicancer early-detection test called Galleri that ...
The cancer test maker still has a bright future.
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The offices of gene sequencing company Illumina Inc are shown in San Diego, California (Reuters) -Shares of Grail fell ...
CHICAGO, June 24 (Reuters) - U.S. cancer diagnostic test maker Grail, which will list its shares on the Nasdaq on Tuesday after being spun out of Illumina (ILMN.O ...
GRAL shares collapsed 50.55% on February 20, 2026, erasing $51.32 per share in value after the Company disclosed its NHS-Galleri trial failed to achieve its primary endpoint. Investors have until ...